Experimental Immunotherapy Could Help High-Risk Bladder Cancer Patients Skip Cystectomy
A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people ...
A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine